enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.900
+0.005 (0.26%)
At close: Jul 15, 2026, 4:00 PM EDT
1.860
-0.040 (-2.11%)
Pre-market: Jul 16, 2026, 8:22 AM EDT
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $127.28 million as of July 16, 2026. Its market cap has decreased by -31.58% in one year.
Market Cap
127.28M
Enterprise Value
-97.83M
1-Year Change
-31.58%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $127.28M, a decrease of -18.36%. That is a compound annual growth rate of -4.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 127.28M | -78.96% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 137.51M |
| Genelux | 129.23M |
| ProMIS Neurosciences | 125.59M |
| Spruce Biosciences | 125.06M |
| Fortress Biotech | 123.24M |
| Vivani Medical | 121.59M |
| Cue Biopharma | 119.67M |
| Anixa Biosciences | 119.08M |